Related references
Note: Only part of the references are listed.Pleiotropic mechanisms facilitated by resveratrol and its metabolites
Barbara Calamini et al.
BIOCHEMICAL JOURNAL (2010)
Quantitative structure-antioxidant activity relationship of trans-resveratrol oligomers, trans-4,4′-dihydroxystilbene dimer, trans-resveratrol-3-O-glucuronide, glucosides: Trans-piceid, cis-piceid, trans-astringin and trans-resveratrol-4′-O-β-D-glucopyranoside
Damian Mikulski et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
3,3′,4,4′,5,5′-Hexahydroxystilbene Impairs Melanoma Progression in a Metastatic Mouse Model
Verena Paulitschke et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Selective Synthesis and Biological Evaluation of Sulfate-Conjugated Resveratrol Metabolites
Juma Hoshino et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Antitumor Activity of Resveratrol and its Sulfated Metabolites against Human Breast Cancer Cells
Michaela Miksits et al.
PLANTA MEDICA (2009)
Metabolism and disposition of resveratrol in the isolated perfused rat liver:: Role of Mrp2 in the biliary excretion of glucuronides
Alexandra Maier-Salamon et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Quantification of free and protein-bound trans-resveratrol metabolites and identification of trans-resveratrol-C/O-conjugated diglucuronides -: Two novel resveratrol metabolites in human plasma
Alexander Burkon et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2008)
Cytotoxic activity of 3,3′,4,4′,5,5′-hexahydroxystilbene against breast cancer cells is mediated by induction of p53 and downregulation of mitochondrial superoxide dismutase
Marek Murias et al.
TOXICOLOGY IN VITRO (2008)
Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent
David J. Boocock et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Cytotoxic and biochemical effects of 3,3',4,4′,5,5′-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells
Zsuzsanna Horvath et al.
EXPERIMENTAL HEMATOLOGY (2006)
Increased transport of resveratrol across monolayers of the human intestinal Caco-2 cells is mediated by inhibition and saturation of metabolites
Alexandra Maier-Salamon et al.
PHARMACEUTICAL RESEARCH (2006)
Antioxidant prooxidant and cytotoxic activity of hydroxylated resveratrol analogues:: structure-activity relationship
M Murias et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells
Z Horvath et al.
EXPERIMENTAL HEMATOLOGY (2005)
Resveratrol analogues as selective cyclooxygenase-2 inhibitors:: synthesis and structure-activity relationship
M Murias et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration
X Vitrac et al.
LIFE SCIENCES (2003)
The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYPIBI
GA Potter et al.
BRITISH JOURNAL OF CANCER (2002)
Share Paper
